Specifications:
Application | Cell culture | ||
Storage Temperature | 2-8°C | ||
Product Type | Culture Medium | Forms | Powder |
Product Brand | Thermo Fisher Scientific™, Gibco | ||
Product Grade | Molecular Biology | ||
Gibco™ CD Hybridoma AGT™ Medium is a serum-free, protein-free, and chemically defined medium specifically designed to support the growth of hybridomas and myeloma cell lines used in monoclonal antibody (mAb) production. Supplied in a dry, granulated format using Advanced Granulation Technology™ (AGT™), this medium offers convenient, fast, and reproducible preparation with rapid solubility and pH stability.
This formulation is animal origin–free (AOF) and does not contain L-glutamine or phenol red, providing flexibility and stability for users who prefer to supplement with GlutaMAX™ or L-glutamine based on specific process needs. It includes sodium pyruvate and sodium bicarbonate to support optimal cell metabolism and buffering.
Manufactured under cGMP-compliant and ISO 13485–certified conditions in an FDA-registered facility, this medium is available for research and further manufacturing use and is backed by a Type II Drug Master File (DMF) for FDA-regulated submissions.
Key Features
- Chemically Defined and Protein-Free: Ideal for antibody purification and regulatory compliance.
- Animal Origin-Free (AOF): Minimizes risk of contamination and variability.
- AGT™ Powder Format: Granulated dry media dissolves rapidly and pH adjusts instantly—reduces prep time.
- Supports Suspension & Adherent Cultures: Promotes high-density growth and IgG production in hybridomas and recombinant myelomas.
- No Glutamine Added: Customize with 8 mM L-glutamine or GlutaMAX™ as needed.
- Regulatory Support: FDA Type II DMF available upon request for submission purposes.
Applications
-
Hybridoma and Myeloma Cell Culture:
- Supports monoclonal antibody production workflows in research and preclinical biomanufacturing.
-
GMP-Ready Cell Expansion:
- Chemically defined formulation suitable for scale-up and further manufacturing.
-
Antibody Purification Workflows:
- Low protein and serum-free composition facilitates downstream purification.
-
Cholesterol-Dependent Cell Culture:
- NS0 and similar cell lines can be supported with the addition of 250× Cholesterol Lipid Concentrate.
Specifications
Attribute | Detail |
---|---|
Product Name | CD Hybridoma AGT™ Medium |
Catalog Numbers | 12372025 (1 L), 12372017 (10 L), 12372001 (100 L) |
Form | Granulated Powder (AGT™) |
Cell Type Supported | Hybridomas, Myelomas |
Serum Level | Serum-Free |
With Additives | Sodium Pyruvate, Sodium Bicarbonate |
Without Additives | No Glutamine, No Phenol Red |
Sterility | Non-sterile (requires sterile reconstitution) |
Endotoxin Level | ≤10 EU/mL |
Storage Conditions | 2–8°C, dry and protected from light |
Shipping Conditions | Gel packs |
Shelf Life | 24 months |
Regulatory Compliance | cGMP-compliant, ISO 13485-certified, FDA-registered |
Regulatory Support | Type II Drug Master File (DMF) available upon request |
Intended Use | Research or Further Manufacturing Use Only |
Gibco™ CD Hybridoma AGT™ Medium provides a scalable, high-performance, and regulatory-friendly solution for antibody production. Its chemically defined, animal-origin-free formulation and convenient granulated powder format make it ideal for bioprocessing workflows, enabling efficient preparation and consistent hybridoma performance.
- Pack Size: 1L 10L 100L